Virset G 0.15% Ophthalmic Gel
Marketer
Amwin Pharmaceuticals
Salt Composition
Ganciclovir (0.15% w/w)
Overview Virset G 0.15% Ophthalmic Gel
Ganciclovir 0.15% ophthalmic gel (Virset G equivalent) is an antiviral medication indicated for treating cytomegalovirus (CMV) infections in immunocompromised individuals post-organ or bone marrow transplant. This treatment mitigates the risk of vision loss from CMV retinitis, a severe ocular CMV infection. Apply the gel externally only, adhering strictly to your physician's prescribed dosage and regimen. Maintain hand hygiene before and after administration. Position the applicator near the eye, avoiding contact, and gently dispense the medication into the lower conjunctival sac. Minor, transient eye irritation may occur post-application; however, this typically resolves spontaneously. Persistent irritation warrants medical consultation. Refrain from contact lens use during treatment.
Primary Ingredients of Virset G 0.15% Ophthalmic Gel
No text was provided to rewrite.
Uses of Virset G 0.15% Ophthalmic Gel
CMV Infection
Major Benefits of Virset G 0.15% Ophthalmic Gel:
Apply this medication topically only. Administer as directed by your physician, adhering to the prescribed dosage and timeframe. Consult the product label for application instructions prior to use. Keep the applicator near, but not touching, the eye. Carefully dispense the medication into the lower conjunctival sac.
Common Side effects of Virset G 0.15% Ophthalmic Gel:
- Eye irritation
How to use Virset G 0.15% Ophthalmic Gel:
Apply this medication externally only. Administer it as prescribed by your physician, adhering to the dosage and treatment schedule. Consult the product label for application instructions prior to use. Keep the applicator tip near, but not touching, the eye. Carefully dispense the medication into the lower conjunctival sac.
How Virset G 0.15% Ophthalmic Gel works:
Virset G 0.15% ophthalmic gel combats viral eye infections with its antiviral properties. The medication acts by inhibiting viral replication on the corneal surface, thus halting further virus production and resolving the infection.
SAFETY ADVICE
AlcoholNone
No known drug interactions.
PregnancyCONSULT YOUR DOCTOR
The use of Virset G 0.15% Ophthalmic Gel during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Virset G 0.15% Ophthalmic Gel while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Using Virset G 0.15% Ophthalmic Gel may induce adverse reactions that impair driving ability. These reactions can include drowsiness, dizziness, confusion, tremors, loss of equilibrium, or seizures.
KidneyNone
No known drug interactions.
LiverNone
No known drug interactions.
What if you forget to take Virset G 0.15% Ophthalmic Gel :
Should you forget a dose of Virset G 0.15% Ophthalmic Gel, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Virset G 0.15% Ophthalmic Gel
| Label | Value |
|---|---|
| Pharmaceutical Category | Nucleotide base mimic |
| Potential for Dependence | None. |
| Type of Medication | Eye medication |
| Mechanism of Action | Medications against viruses (excluding HIV) |
3,018 People bought this recently